CM
CLB icon

Crestline Management’s Core Laboratories CLB Stock Holding History

Crestline Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-4,242
Closed -$509K – 120
2016
Q4 		$509K Buy
+4,242
New +$470K 0.13% 53

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 16.04% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Crestline Management's CLB Position: Q1 2017 in Review

Crestline Management sold out of Core Laboratories (CLB) in Q1 2017, closing a stake of 4,242 shares — an estimated $509K sold.

Crestline Management first reported a position in CLB in Q4 2016 and held it in 1 quarter. The position peaked at $509K in Q4 2016. 360 funds tracked by Wall St. Rank hold CLB as of Q1 2017.

  • Crestline Management reported no remaining Core Laboratories position as of Q1 2017 after selling out during the quarter.
  • Crestline Management sold 4,242 Core Laboratories shares in Q1 2017, an estimated $509K.
  • Crestline Management first reported a position in Core Laboratories in Q4 2016 and held it in 1 quarter.
  • Crestline Management's Core Laboratories position peaked at $509K in Q4 2016.
  • 360 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2017.

Based on Crestline Management's 13F filing for Q1 2017, filed 12 May 2017.